Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Laboratory Corporation of America Holdings    LH

LABORATORY CORPORATION OF AMERICA HOLDINGS

(LH)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
03/01/2021 03/02/2021 03/03/2021 03/04/2021 03/05/2021 Date
241.5(c) 243.65(c) 239.92(c) 234.9(c) 237.8(c) Last
865 040 776 109 514 121 684 367 653 225 Volume
+0.66% +0.89% -1.53% -2.09% +1.23% Change
More quotes
Financials (USD)
Sales 2021 14 278 M - -
Net income 2021 1 738 M - -
Net Debt 2021 3 788 M - -
P/E ratio 2021 13,3x
Yield 2021 -
Sales 2022 13 501 M - -
Net income 2022 1 162 M - -
Net Debt 2022 3 319 M - -
P/E ratio 2022 19,3x
Yield 2022 -
Capitalization 23 209 M 23 209 M -
EV / Sales 2021 1,89x
EV / Sales 2022 1,96x
Nbr of Employees 68 780
Free-Float 99,3%
More Financials
Company
Laboratory Corporation of America Holdings is the No. 2 clinical laboratory in the United States. Net sales (including intragroup) break down by activity as follows: - supply of testing services (59.5%): routine testing, patient diagnosis, disease monitoring and treatment, and other services; - supply of genomic and esoteric testing services (40.5%). Net sales are distributed geographically as follows : the... 
More about the company
Notations Surperformance© of Laboratory Corporation of America Holdings
Trading Rating : Investor Rating :
More Ratings
All news about LABORATORY CORPORATION OF AMERICA HOLDINGS
03/03LABORATORY OF AMERICA  : Changes in Registrant's Certifying Accountant (form 8-K..
AQ
02/25LABORATORY OF AMERICA  : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDI..
AQ
02/24WALGREENS BOOTS ALLIANCE  : to Sell Pixel by Labcorp Covid-19 PCR Test Home Coll..
DJ
02/24WALGREENS  : to Make Pixel by Labcorp™ COVID-19 PCR Test Home Collection K..
BU
02/23ADAPTIVE BIOTECHNOLOGIES  : Expands Collaboration Agreement With Labcorp
MT
02/23LABCORP  : is Scheduled to Speak at Citi's 2021 Healthcare Services, Medtech, To..
BU
02/19INSIDER TRENDS : Insider at Laboratory Corp of America Holdings Converts/Exercis..
MT
02/18LABORATORY OF AMERICA  : Pacific Biosciences Sequel II Systems Deployed to Scale..
AQ
02/17INSIDER TRENDS : Laboratory Corp of America Holdings Insider Converts Option/Der..
MT
02/17INSIDER TRENDS : Insider at Laboratory Corp of America Holdings Acquires Stock V..
MT
02/17INSIDER TRENDS : Insider at Laboratory Corp of America Holdings Acquires Stock V..
MT
02/17LABORATORY OF AMERICA  : Adds New Antigen Test to Screen for COVID-19 Infection
MT
02/17LABCORP  : Adds High Sensitivity Antigen Test to Screen for Active COVID-19 Infe..
BU
02/17LABORATORY OF AMERICA  : Amy Summy, Chief Marketing Officer of Labcorp, Named to..
AQ
02/16LABORATORY OF AMERICA  : Amy Summy, Chief Marketing Officer of Labcorp, Named to..
BU
More news
News in other languages on LABORATORY CORPORATION OF AMERICA HOLDINGS
2020ROCHE  : erhält FDA-Notfallzulassung für Sars-CoV-2-Antikörpertest
2020LABORATORY CORPORATION OF AMERICA HO : Veröffentlichung des Quartalsergebnisses
2020LABORATORY CORPORATION OF AMERICA HO : publication des résultats trimestriels
2020GENFIT  : signe un contrat exclusif de licence avec LabCorp pour un test de la N..
2020LABORATORY CORPORATION OF AMERICA HO : Veröffentlichung des Halbjahresergebnisse..
More news
Analyst Recommendations on LABORATORY CORPORATION OF AMERICA HOLDINGS
More recommendations
Stock Trading Strategies
LABORATORY CORPORATION OF AMERICA HOLDINGS - 02/01
Increase of volatility
BUY
More Stock Trading Analysis
Chart LABORATORY CORPORATION OF AMERICA HOLDINGS
Duration : Period :
Laboratory Corporation of America Holdings Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends LABORATORY CORPORATION OF AMERICA HOLDINGS
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 18
Average target price 263,07 $
Last Close Price 237,80 $
Spread / Highest target 26,2%
Spread / Average Target 10,6%
Spread / Lowest Target -12,1%
EPS Revisions
Managers and Directors
NameTitle
Adam H. Schechter President, Chief Executive Officer & Director
Glenn Andrew Eisenberg Chief Financial Officer, Treasurer & Executive VP
Lance V. Berberian Chief Information Officer & Senior Vice President
Brian J. Caveney Chief Medical Officer, EVP & President-Diagnostics
Stephen M. Anderson Chief Scientific Officer-Covance & Senior VP
Sector and Competitors